April 4, 2015 Newton, Massachusetts Applied Tissue Technologies has been awarded a Phase II SBIR grant to further investigate it's next generation NPWT (negative pressure wound therapy) under contract # W81XWH-14-C-0015 and sponsored by the DHP/ Army. Click to follow link to SBIR reference page. The two year…
October 10, 2014 Newton, MA Applied Tissue Technologies was issued yet another patent for their new next generation negative pressure device. The device eliminates the use of an intermediary layer such as foam or gauze with the use of an innovative and proprietary design utilizing microstructures. The elimination of the…
April 17, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: An additional patent for simplifying the use of negative pressure wound therapy with a breakthrough design. The new patent is granted in China. The technology simplifies the administration of negative pressure wound therapy “NPWT”…
April 10, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: An additional patent for simplifying the use of negative pressure wound therapy with a breakthrough design. The new patent is allowed in Australia. The technology simplifies the administration of negative pressure wound therapy “NPWT”…
February 4, 2014 Newton, Massachusetts Following on the heels of the issuance of USPTO patent number 8,632,523, describing a revolutionary method and device to administer Negative Pressure Wound Therapy (NPWT), Applied Tissue Technologies has been awarded a Phase I SBIR grant to investigate negative pressure wound therapy…
January 30, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: The issuance of a new patent simplifying the use of negative pressure wound therapy with a breakthrough design. The USPTO patent entitled "Wound Treatment Device Employing Negative Pressure," was issued on…
Applied Tissue Technologies and SteadMed® Medical have partnered to bring distribution of Xpansion to the Western Hemisphere. www.steadmed.com
Applied Tissue Technologies LLC has obtained ISO 13485 certification using BSI as its notified body. We have also secured CMDCAS certification in Canada for the Xpansion Skin Grafting Instruments and continue to work toward CE certification for distribution in Europe.
Applied Tissue Technologies has enrolled the Xpansion Skin Grafting Instrument kit in two clinical trials. The trials will start in the 2nd quarter of 2013, and provide data to support the efficacy of the device and procedure (to transplant minced split thickness skin autografts (STSG)s. Additionally the use of negative…